[Proceedings: Therapy of hemophilia A and B].
D000614:Aminocaproates / Q000627:therapeutic use; D001803:Blood Transfusion; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D006395:Hemarthrosis / Q000150:complications / Q000209:etiology; D006417:Hematuria / Q000628:therapy; D006467:Hemophilia A / Q000150:complications / Q000628:therapy*; D002836:Hemophilia B / Q000628:therapy*; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012712:Serum Globulins / Q000627:therapeutic use; D000074402:Synovectomy; D013585:Synovitis / Q000209:etiology
D000614:Aminocaproates; D004966:Estrogens, Conjugated (USP); D007166:Immunosuppressive Agents; D012712:Serum Globulins; D005169:Factor VIII
La terapia dell'emofilia A e.